article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Developing a new drug is a monumental achievement — the reward of years of research and innovation. AI in pharma R&D is one of the latest innovations helping teams apply existing knowledge to new problems. AI in pharma R&D is one of the latest innovations helping teams apply existing knowledge to new problems.

article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance. Diana Spencer, Senior Digital Content Editor, DDW The post EFPIA states AI rules must “enable not hinder” pharma R&D appeared first on Drug Discovery World (DDW).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Transforming pharma R&D with a scientist-centric approach to AI & automation

pharmaphorum

Deloitte anticipates that the next five years could see AI dramatically accelerating the drug discovery process. With a scientist-centric mindset, we believe R&D can be transformed in a far shorter timeframe. About the author.

article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

The Pharma Data

.–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.